Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BATS BZX Real-Time Price
As of 11:58am ET
 +0.20 / +0.60%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 30 analysts offering 12-month price forecasts for AstraZeneca have a median target of 34.48, with a high estimate of 46.53 and a low estimate of 25.92. The median estimate represents a +1.99% increase from the last price of 33.81.

Analyst Recommendations

The current consensus among 31 polled investment analysts is to Hold stock in AstraZeneca. This rating has held steady since September, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 37.30%
Growthannually -1.11%


Growthquarterly 5.77%
Growthannually -4.81%
Key to the earnings and sales forecast charts.